Structure-Function Studies of the Modular Human Mediator Coactivator Complex
Structure-Function Studies of the Modular Human Mediator Coactivator Complex
批准号:
7816386
负责人:
ROBERT G ROEDER
金额:
$47.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-08-31
关键词:
AddressAffectAntibodiesArchitectureAreaBiochemicalBiologicalClassificationColorectal CancerComplexCongenital Heart DefectsDNA-Directed RNA PolymeraseDiseaseEpitopesEukaryotaFoundationsFutureGenesGeneticGenetic TranscriptionGoalsHeterogeneityHumanIndividualMacromolecular ComplexesMalignant NeoplasmsMediator of activation proteinMethodsMolecularMonoclonal AntibodiesNatureNerve DegenerationPhaseProcessProteinsRNA Polymerase IISignal TransductionSourceStructureStructure-Activity RelationshipTechnologyTranscription CoactivatorWorkYeastsbasehuman diseaseinsightpublic health relevancetool
中文摘要
描述(由申请人提供):本申请涉及广泛的挑战领域06:使能技术和特定的挑战主题06- gm -101:大分子复合物的结构分析。它的重点是多蛋白介质复合物,它被认为是真核生物中几乎所有RNA聚合酶ii转录基因转录的关键辅激活因子。通过其与转录调节因子和RNA聚合酶机制相互作用的能力以及其多种功能能力,Mediator被认为是转录信号最终处理的主要通道。一些中介亚基的异常表达也与包括癌症、心脏异常和神经变性在内的人类疾病有关。尽管它们有共同的进化起源,酵母和哺乳动物复合体却有很大的不同。与酵母介质的情况不同,遗传研究强调了重要的结构-功能关系,并为生化研究指明了道路,技术问题使得很难超越对30个亚基哺乳动物复合体的结构及其功能的粗略描述。尚未解决的问题涉及综合体的基本核心的定义以及在不同条件下影响其功能的其他因素的性质。在这里,我们建议采用一种系统的方法来定义核心人类复合体的模块化结构(特别是当它涉及其基本功能时),并开发从各种生物来源中纯化完整复合体及其相互作用蛋白质的方法。为了实现这些目标,我们的目标是(i)重组地生成模块化中介复合体的最小泛函导数;(ii)培养针对特定中介表位的单克隆抗体,这将使与相互作用因子相关的天然复合物易于纯化。因此,这些工具的可用性有望为人类中介领域的下一阶段研究提供一个快速启动。
英文摘要
DESCRIPTION (provided by applicant): This application addresses broad Challenge Area 06: Enabling Technologies and specific Challenge Topic 06-GM-101: Structural Analysis of Macromolecular Complexes. It focuses on the multiprotein Mediator complex, which has been implicated as a critical coactivator for transcription of essentially all RNA polymerase II-transcribed genes in eukaryotes. Through its ability to interact with both transcriptional regulators and the RNA polymerase machinery as well as through its multiple functional capabilities, Mediator is believed to be the main channel through which transcriptional signals are ultimately processed. Aberrant expression of several Mediator subunits has also been implicated in human diseases that include cancer, heart abnormalities, and neural degeneration. Despite their common evolutionary origins, the yeast and mammalian complexes have diverged considerably. Unlike the situation for the yeast Mediator, where genetic studies have highlighted important structure-function relationships and led the way for biochemical studies, technical issues have made it difficult to go beyond a gross description of the architecture of the 30-subunit mammalian complex and its function. Unaddressed issues relate to definition of the essential core of the complex and to the nature of other factors that impinge on its function under different conditions. Here we propose to undertake a systematic approach both to define the modular architecture of the core human complex (especially as it pertains to its essential functions) and to develop methods to purify the intact complex and its interacting proteins from a diverse range of biological sources. Towards these goals we aim (i) to recombinantly generate a minimal functional derivative of the modular Mediator complex; and (ii) to raise monoclonal antibodies against defined Mediator epitopes that will allow facile purification of the natural complex in association with interacting factors. Availability of these tools is thus expected to provide a jump-start to the next phase of studies in the human Mediator field.
PUBLIC HEALTH RELEVANCE: The multisubunit Mediator has emerged as one of the most critical factors involved in the precise transcription of protein-encoding genes, the aberrant expression of which is a cause of many human diseases, especially cancer. Although several individual subunits of the human Mediator have been directly implicated in diseases including colorectal cancer, heart abnormalities and neural degeneration, detailed studies of the human Mediator have faced significant technical challenges arising from its scarcity, extraordinary size and heterogeneity with respect to its composition. By directly addressing these challenges, this proposal aims to reveal new insights into the composition of the human Mediator, and, by generating important new antibody-based tools; it aims to lay the foundation for anticipated future work into the molecular bases of many transcription-related diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic studies of transcription initiation and elongation functions of an RNA polymerase II variant, Pol II(G), that is implicated in development and cancer
-
批准号:10503451
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2022
-
负责人:ROBERT G ROEDER
-
依托单位:
Mechanistic studies of transcription initiation and elongation functions of an RNA polymerase II variant, Pol II(G), that is implicated in development and cancer
-
批准号:10670981
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2022
-
负责人:ROBERT G ROEDER
-
依托单位:
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis
-
批准号:10303052
-
项目类别:
-
资助金额:$73.75万
-
财政年份:2019
-
负责人:ROBERT G ROEDER
-
依托单位:
Molecular mechanisms of estrogen receptor-dependent transcription regulation
-
批准号:10545758
-
项目类别:
-
资助金额:$65.08万
-
财政年份:2019
-
负责人:ROBERT G ROEDER
-
依托单位:
Molecular mechanisms of estrogen receptor-dependent transcription regulation
-
批准号:10322679
-
项目类别:
-
资助金额:$65.08万
-
财政年份:2019
-
负责人:ROBERT G ROEDER
-
依托单位:
Biological roles and Mediator-dependent transcription mechanisms of RNA polymerase II(G)
-
批准号:9009066
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2015
-
负责人:ROBERT G ROEDER
-
依托单位:
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
-
批准号:8564107
-
项目类别:
-
资助金额:$55.28万
-
财政年份:2013
-
负责人:ROBERT G ROEDER
-
依托单位:
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
-
批准号:8719062
-
项目类别:
-
资助金额:$54.85万
-
财政年份:2013
-
负责人:ROBERT G ROEDER
-
依托单位:
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
-
批准号:9271811
-
项目类别:
-
资助金额:$56.55万
-
财政年份:2013
-
负责人:ROBERT G ROEDER
-
依托单位:
Function and targeting of a stable transcription factor complex in leukemia
-
批准号:8513945
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2011
-
负责人:ROBERT G ROEDER
-
依托单位:
Function and targeting of a stable transcription factor complex in leukemia
-
批准号:8163071
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2011
-
负责人:ROBERT G ROEDER
-
依托单位:
INTERACTORS OF GDOWN1
-
批准号:8361525
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2011
-
负责人:ROBERT G ROEDER
-
依托单位:
Function and targeting of a stable transcription factor complex in leukemia
-
批准号:8882320
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2011
-
负责人:ROBERT G ROEDER
-
依托单位:
Function and targeting of a stable transcription factor complex in leukemia
-
批准号:10322366
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2011
-
负责人:ROBERT G ROEDER
-
依托单位:
Function and targeting of a stable transcription factor complex in leukemia
-
批准号:8332780
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2011
-
负责人:ROBERT G ROEDER
-
依托单位:
INTERACTORS OF GDOWN1
-
批准号:8169151
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2010
-
负责人:ROBERT G ROEDER
-
依托单位:
INTERACTORS OF GDOWN1
-
批准号:7954119
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2009
-
负责人:ROBERT G ROEDER
-
依托单位:
Structure-Function Studies of the Modular Human Mediator Coactivator Complex
-
批准号:7939854
-
项目类别:
-
资助金额:$47.21万
-
财政年份:2009
-
负责人:ROBERT G ROEDER
-
依托单位:
INTERACTORS OF GDOWN1
-
批准号:7722269
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2008
-
负责人:ROBERT G ROEDER
-
依托单位:
FNS OF SII & P300 IN PRODUCTIVE ACTIVATOR-DEPENDENT TRANSCRIPTION OF CHROMATIN
-
批准号:7722249
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2008
-
负责人:ROBERT G ROEDER
-
依托单位:
海外基金